TGFB1 and breast cancer: Interestingly, late-stage breast cancers, including triple-negative breast cancers (TNBCs), become insensitive to the tumor suppressing activities of TGF-β, and instead readily exhibit epithelial-mesenchymal transition (EMT), invasive, and metastatic phenotypes in response to TGF-β [22].